YTS-107

N/A

Report date: 2024/11/13 15:02:07

Base Information

Drug NameYTS-107

Drug Alias NameYTS-106

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionLeukocyte immunoglobulin-like receptor subfamily B member 4 antagonists

TargetsLeukocyte immunoglobulin-like receptor subfamily B member 4

Therapy Area/IndicationsLeukemia, Myeloid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesChina Immunotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChina Immunotech Co Ltd

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid

Inactive IndicationsN/A

Other Information

ATC CodeN/A